|
|
||||||||
Journal of Applied Physiology, Vol 68, Issue 3 1059-1068, Copyright © 1990 by American Physiological Society
ARTICLES |
C. R. Chen, N. F. Voelkel and S. W. Chang
Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, Denver 80262.
We studied the synergistic interaction between platelet-activating factor (PAF) and protamine sulfate, a cationic protein that causes pulmonary endothelial injury, in isolated rat lungs perfused with a physiological salt solution. A low dose of protamine (50 micrograms/ml) increased pulmonary artery perfusion pressure (Ppa) but did not increase wet lung-to-body weight ratio after 20 min. Pretreatment of the lungs with a noninjurious dose of PAF (1.6 nM) 10 min before protamine markedly potentiated protamine-induced pulmonary vasoconstriction and resulted in severe lung edema and increased lung tissue content of 6-keto-prostaglandin F1 alpha, thromboxane B2, and leukotriene C4. Pulmonary microvascular pressure (Pmv), measured by double occlusion, was markedly increased in lungs given PAF and protamine. These potentiating effects of PAF were blocked by WEB 2086 (10(-5) M), a specific PAF receptor antagonist. Pretreatment of the lungs with a high dose of histamine (10(-4) M) failed to enhance the effect of protamine on Ppa, Pmv, or wet lung-to-body weight ratio. Furthermore, PAF pretreatment enhanced elastase-, but not H2O2-, induced lung edema. To assess the role of hydrostatic pressure in edema formation, we compared lung permeability-surface area products (PS) in papaverine-treated lungs given either protamine alone or PAF + protamine and tested the effect of mechanical elevation of Pmv on protamine-induced lung edema. In the absence of vasoconstriction, PAF did not potentiate protamine-induced increase in lung PS. On the other hand, mechanically raising Pmv in protamine-treated lungs to a level similar to that measured in lungs given PAF + protamine did not result in a comparable degree of lung edema. We conclude that PAF potentiates protamine-induced lung edema predominantly by enhanced pulmonary venoconstriction. However, a pressure-independent effect of PAF on lung vasculature cannot be entirely excluded.
This article has been cited by other articles:
![]() |
M. Berthe, R. Stiufiuc, B. Grandidier, D. Deresmes, C. Delerue, and D. Stievenard Probing the Carrier Capture Rate of a Single Quantum Level Science, January 25, 2008; 319(5862): 436 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gao, S. Dhanakoti, E. M. Trevino, F. C. Sander, A. M. Portugal, and J. U. Raj Effect of oxygen on cyclic GMP-dependent protein kinase-mediated relaxation in ovine fetal pulmonary arteries and veins Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L611 - L618. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. DAZ, J. A. BARBER, R. MARRADES, K. CHUNG, J. ROCA, and R. RODRIGUEZ-ROISIN Inhibition of PAF-induced Gas Exchange Defects by Beta-adrenergic Agonists in Mild Asthma Is Not Due to Bronchodilation Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 17 - 22. [Abstract] [Full Text] |
||||
![]() |
Y. Gao, H. Zhou, and J. U. Raj Endothelium-Derived Nitric Oxide Plays a Larger Role in Pulmonary Veins Than in Arteries of Newborn Lambs Circ. Res., April 1, 1995; 76(4): 559 - 565. [Abstract] [Full Text] |
||||
![]() |
D. S. Kucukaksu, S. F. Katircioglu, G. Saydam, M. Bozdayi, B. Mavitas, O. Tasdemir, and K. Bayazit Beneficial Effects of Prostacyclin on Pulmonary Function During Heparin Reversal with Protamine Vascular and Endovascular Surgery, May 1, 1993; 27(4): 264 - 267. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |